24 / 64
22
SCIENTIFIC PROGRAMME
| PROGRAMME & EXHIBITION GUIDE
Symposium
New developments in systemic treatment
16:30 - 17:45 | Auditorium
Chair: J.E. Bakema (The Netherlands)
Chair: J. Vermorken (Belgium)
16:30 Is there still a role for targeted signaling agents in head and neck
cancer?
Speaker: C. Le Tourneau (France)
SP-035
16:55 Immunity and immune toxicity: clinical management of immune
checkpoint inhibition
Speaker: U. Keilholz (Germany)
SP-036
17:20 Immunotherapy beyond anti PD1 inhibitors
Speaker: P. Coulie (Belgium)
SP-037